Pharmacologic heterogeneity of human lung and colon cells: effect of terfenadine and cetirizine.
H1-blockers may have antiallergic properties which cause the blocking of eicosanoid release, and the effect of these drugs may differ according to the phenotype of mast cells. This study examined the ability of terfenadine and cetirizine to inhibit the release of arachidonic acid-derived mediators from human lung and colon cells. Dispersed cells were challenged with anti-IgE in the presence or absence of 10 microM of terfenadine or cetirizine, and the release of prostaglandin (PG)D2 and leukotriene (LT)C4/D4 was assessed by enzyme immunoassay (EIA). Terfenadine caused significant inhibition of both PGD2 and LTC4/D4 (49 +/- 9 and 29 +/- 19%, respectively) from human lung cells but had a less marked effect on PGD2 release from human colon cells (21 +/- 9% for PGD2 and 18 +/- 9% for LTC4/D4). In contrast, although cetirizine caused significant inhibition of both mediators measured in lung cells (38 +/- 16% for PGD2 and 34 +/- 19% for LTC4), it did not cause any significant inhibition of either mediator from human colon cells. These findings suggest that H1-antagonists may have additional properties, and the differential effects of cetirizine on lung and colon tissue may indicate differences in mast cell phenotype.
Fabre
J M
JM
Clinique des Maladies Respiratoires and CJF-INSERM 92-10, Centre Hospitalier Universitaire, Montpellier, France.
Marty-Ané
C
C
Alauzen
M
M
Souques
F
F
Bousquet
J
J
Campbell
A M
AM
D000328:Adult; D000368:Aged; D000888:Antibodies, Anti-Idiotypic / Q000494:pharmacology; D002478:Cells, Cultured; D017332:Cetirizine / Q000494:pharmacology*; D003106:Colon / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D015777:Eicosanoids / Q000378:metabolism; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D006801:Humans; D007073:Immunoglobulin E / Q000494:pharmacology; D016859:Lipoxygenase Inhibitors / Q000494:pharmacology; D008168:Lung / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism; D008875:Middle Aged; D016593:Terfenadine / Q000494:pharmacology*
D000888:Antibodies, Anti-Idiotypic; D016861:Cyclooxygenase Inhibitors; D015777:Eicosanoids; D006634:Histamine H1 Antagonists; D016859:Lipoxygenase Inhibitors; D007073:Immunoglobulin E; D016593:Terfenadine; D017332:Cetirizine